About the Authors

David J. DeGraff

david.degraff@vanderbilt.edu

Affiliation Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

Peter E. Clark

Affiliation Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

Justin M. Cates

Affiliation Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

Hironobu Yamashita

Affiliation Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

Victoria L. Robinson

Affiliation Department of Surgery, University of Chicago, Chicago, Illinois, United States of America

Xiuping Yu

Affiliation Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

Mark E. Smolkin

Affiliation Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, United States of America

Sam S. Chang

Affiliation Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

Michael S. Cookson

Affiliation Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

Mary K. Herrick

Affiliation Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

Shahrokh F. Shariat

Affiliation Department of Urology, Weill Cornell Medical College, New York, New York, United States of America

Gary D. Steinberg

Affiliation Department of Surgery, University of Chicago, Chicago, Illinois, United States of America

Henry F. Frierson

Affiliation Department of Pathology, University of Virginia, Charlottesville, Virginia, United States of America

Xue-Ru Wu

Affiliation Deparments of Urology and Pathology, New York University, New York, New York, United States of America

Dan Theodorescu

Affiliation University of Colorado Comprehensive Cancer Center, Aurora, Colorado, United States of America

Robert J. Matusik

Affiliations Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America, Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America, Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

Competing Interests

DJD, PEC, JMC, SFS, HFF, DT, and RJM have filed an invention disclosure with Vanderbilt University for the use of FOXA1 as a diagnostic and/or prognostic marker for bladder cancer. There are no further products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: DJD PEC SSC MSC HFF XW DT RJM. Performed the experiments: DJD JMC HY VLR XY MKH. Analyzed the data: DJD JMC MES SFS HFF XW DT RJM. Contributed reagents/materials/analysis tools: DJD PEC VLR GDS HFF XW DT RJM. Wrote the paper: DJD PEC JMC VLR MES HFF XW DT RJM.